Status:
COMPLETED
Beaumont Health Large-scale Automated Serologic Testing for COVID-19
Lead Sponsor:
Corewell Health East
Conditions:
COVID-19
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine how peoples' bodies respond to exposure to COVID-19. Employees of Beaumont Health in Michigan who are older than 18 years may be eligible to participate. Part...
Detailed Description
Beaumont Health is an eight-hospital regional health care system with a total of 3,337 beds, 38,000 employees and 5,000 physicians in Southeast Michigan. In the first 3 weeks of the COVID-19 pandemic ...
Eligibility Criteria
Inclusion
- Beaumont Health employees and affiliated non-employed physicians and advanced practice providers
- Immediate family members of Beaumont Health employees, affiliated non-employed physicians and advance practice providers who have tested positive for SARS-CoV-2 antibodies
- non-Beaumont employees who are specifically invited to participate in the study by Dr. Sims, Dr. Kennedy, or Dr. Maine
- All ages
Exclusion
- Decisionally impaired
- Individuals symptomatic for COVID-19 \<72 hours prior to testing appointment
Key Trial Info
Start Date :
April 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 19 2021
Estimated Enrollment :
20614 Patients enrolled
Trial Details
Trial ID
NCT04349202
Start Date
April 10 2020
End Date
January 19 2021
Last Update
September 5 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beaumont Health System
Royal Oak, Michigan, United States, 48073
2
Beaumont Health
Royal Oak, Michigan, United States, 48073